Name: Therapies for Treatment-Resistant Depression. Neuropharmacology and Neurostimulation
Price: 629.18 PEN
Availability: InStock
Author: Dennis Charney;James , New York, NY, USA) Murrough
ISBN: 9780443160059

portada Therapies for Treatment-Resistant Depression. Neuropharmacology and Neurostimulation

Therapies for Treatment-Resistant Depression. Neuropharmacology and Neurostimulation

Formato

Libro Físico

Editorial

Academic Press Inc

Autor

Dennis Charney;James , New York, NY, USA) Murrough

Año

2025

N° páginas

410

Encuadernación

Tapa Blanda

Dimensiones

23.50 x 19.10 cm

ISBN13

9780443160059

Therapies for Treatment-Resistant Depression. Neuropharmacology and Neurostimulation

Dennis Charney;James , New York, Ny, Usa) Murrough (Autor) · Academic Press Inc · Tapa Blanda

Más barato Libro Nuevo Importado

Envío: 18 a 23 días háb.

S/ 1.398,17S/ 629,18

-55%

Más rápido Libro Nuevo Importado

Envío: 12 a 19 días háb.

S/ 1.721,20S/ 774,54

-55%

Costos de importación incluídos en el precio ✅

Libro Nuevo Más barato

Quedan 100 unidades

S/ 629,18

Llega entre el 24 Ago y el 01 Sep a CERCADO DE LIMA, Lima. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Therapies for Treatment-Resistant Depression. Neuropharmacology and Neurostimulation"

Therapies for Treatment-Resistant Depression: Neuropharmacology and Neurostimulation provides readers with an authoritative, comprehensive and targeted treatment guide. The first section reviews the essential knowledge and methods of clinical neuroscience and neuropsychopharmacological techniques as they apply to novel treatment discovery for depression. This is followed by detailed chapters on ketamine, esketamine, other glutamate modulators in development, GABA modulators, neuropeptides, anti-inflammatory agents, and other classes of novel therapeutics under study for TRD and related mood disorders. The last section consists of a set of chapters of special interest that includes current and future research directions, development of psilocybin-based interventions and other psychedelic compounds currently under study for TRD and advances in biomarker-guided and personalized treatment. Edited by world renowned experts in the field, this book is the ultimate resource for researchers and clinicians.